{
    "2019-02-19": [
        [
            {
                "time": "2018-12-31",
                "original_text": "Eli Lilly and Co (LLY) Files 10-K for the Fiscal Year Ended on December 31, 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "10-K",
                        "Fiscal Year"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Merck's (MRK) Stock Up Almost 50% in a Year: Here's Why",
                "features": {
                    "keywords": [
                        "Merck",
                        "Stock Up",
                        "50%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Bayer Obtains Full Rights to Vitrakvi From Lilly's Loxo",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Vitrakvi",
                        "Lilly",
                        "Loxo"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "What Are Teva Pharmaceuticalâ€™s Key Growth Drivers in 2019?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Growth Drivers",
                        "2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Pfizer-Lilly drug shown to help reduce back pain in late-stage trial",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lilly",
                        "drug",
                        "back pain",
                        "trial"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Higher dose of Pfizer-Lilly drug helps reduce back pain in study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lilly",
                        "drug",
                        "higher dose",
                        "back pain",
                        "study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lilly",
                        "Tanezumab",
                        "Phase 3",
                        "Chronic Low Back Pain"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}